Coverage Of Anti-Counterfeit Policy Debate Varies Widely Across Global Media 02/08/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments Are counterfeit products first and foremost a threat to human health and safety or is provoking anxiety just a clever way for wealthy nations to create sympathy for increased protection of their intellectual property rights? In Geneva the debate is raging, but a look at a sample of coverage of this issue in the world’s news media shows it can vary greatly.
Experts, Policymakers Debate Solutions For Counterfeit Products 30/07/2010 by William New, Intellectual Property Watch Leave a Comment A group of policymakers and other experts met this month in Geneva to discuss counterfeit and unsafe products and wrestled with possible balanced solutions to the problem. The event was hosted by the United States mission and supported by the US Chamber of Commerce. It included US Ambassador to the UN Betty E. King, among dozens of others.
Global AIDS Conference Sees Pledge Of Access, Call For Funding; IP Rights Discussed 28/07/2010 by Catherine Saez, Intellectual Property Watch Leave a Comment The global AIDS community meeting in Vienna last week ended with renewed determination to fight the epidemic but underlined an urgent need for increased funding to sustain scientific advances and universal access. Some warned against an intellectual property rights enforcement push threatening global access in particular through bilateral and regional trade agreements.
The WHO’s Complex Path On Counterfeiting, R&D Financing, Pandemics 27/07/2010 by Emma Broster for Intellectual Property Watch Leave a Comment The World Health Organisation is following a complicated timeline for new mandates on combating fake medicines, creating alternative financing mechanisms for research and development on neglected diseases, and improving pandemic influenza preparedness.
Agencies Talk Cooperation On Medicines Access; Stakeholders Cautious 19/07/2010 by Catherine Saez, Intellectual Property Watch 1 Comment Key international agencies for health, trade and intellectual property on Friday jointly organised a symposium on access to medicines in an effort to gather information and expertise as a basis of a collaborative response to the challenges of public health.
AIDS Conference Campaigns For International Focus, Funding and Research 19/07/2010 by Catherine Saez, Intellectual Property Watch 1 Comment The 18th International AIDS conference opened its doors in Vienna on Sunday with a purpose of keeping the HIV issue high among international priorities in the context of a global economic crisis, and to promote universal access to treatment.
WHO Flu Misconduct Debate Polarising As Independent Review Advances 07/07/2010 by Kaitlin Mara for Intellectual Property Watch 5 Comments “Exactly a year ago, a very bad decision was taken” by the World Health Organization that now seems “unscientific and irrational,” said Council of Europe parliamentarian Paul Flynn in a late June presentation of a new report on the WHO’s actions during the 2009 influenza pandemic. But opinions heard at an ongoing review of the WHO’s pandemic response were mixed, with some praising the organisation’s work to protect public health and others critiquing what they say is suspicious secrecy.
The Biosimilars Pathway: An Invitation To Litigation 11/06/2010 by Intellectual Property Watch Leave a Comment Lynn C. Tyler writes: The litigation provisions of the recently-enacted legislation establishing a pathway to bring biosimilars to market contain “patent” ambiguities in key areas, particularly whether the various lists of patents to be litigated are exclusive. Courts will have to resolve these issues over the next several years, likely at great (and unnecessary) expense and uncertainty to litigants.
Health Waiver, IP Enforcement Discussed At Lively WTO TRIPS Council Meeting 10/06/2010 by Catherine Saez, Intellectual Property Watch 2 Comments After two days of lively discussion, members of a World Trade Organization committee this week agreed to devote a day in October to an in-depth discussion on a waiver to WTO intellectual property rules aimed at boosting access to medicines for poor countries. In addition, some member countries presented concerns about the possible effect of a global enforcement push by developed countries and the Anti-Counterfeiting Trade Agreement (ACTA) under negotiation outside WTO, while ACTA proponent countries sought to allay fears.
UNITAID-Backed Patent Pool Final; Drug Licence Talks Can Begin 08/06/2010 by William New and Kaitlin Mara for Intellectual Property Watch 9 Comments The final step in the establishment of a patent pool under international drug-purchasing mechanism UNITAID was taken today, the UN body announced.